Stay updated on Nivolumab Plus Ipilimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2; this change does not affect study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-26T13:48:44.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The funding/operational status notice was removed from the page; the page now displays the study details without that alert.
    Difference
    0.3%
    Check dated 2025-11-19T08:25:30.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The new screenshot shows no substantive changes to the study details. Core information such as eligibility criteria, locations, and planned outcomes remains the same.
    Difference
    0.3%
    Check dated 2025-10-28T05:20:14.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Significant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 reference removed.
    Difference
    3%
    Check dated 2025-10-06T16:07:33.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T10:09:01.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.2%
    Check dated 2025-09-15T01:11:38.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in NSCLC Clinical Trial page.